SYDNEY/TOKYO -- Share prices of Asian pharmaceutical companies dropped on Friday as U.S. President Donald Trump unleashed a new round of sweeping tariffs that includes duties of 100% on imports of branded drugs, even as the ultimate impact of the move remains unclear.
Pharmaceuticals
Asian drugmakers' shares hit as Trump announces 100% tariff
Duty on branded medicines a blow for makers from Australia to Japan to South Korea
Asia's drugmakers are digesting the implications of the latest U.S. tariff announcement, a 100% duty on imports of branded pharmaceutical products. © Reuters
Read Next
Latest on Pharmaceuticals
